+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Oligometastatic Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oligometastatic Disease - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 66 Pages
  • Global
From
Chondrosarcoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chondrosarcoma - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 68 Pages
  • Global
From
From
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
From
POTELIGEO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

POTELIGEO Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
LYNPARZA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYNPARZA Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
ROZLYTREK Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ROZLYTREK Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
VITRAKVI Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VITRAKVI Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
Biliary Tract Cancers (BTCs) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Biliary Tract Cancers (BTCs) - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 126 Pages
  • Global
From
From
Prostate cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Prostate cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Brain Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Multiple Myeloma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Multiple Myeloma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Osteosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Osteosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Cancer Cachexia - Pipeline Insight, 2025 - Product Thumbnail Image

Cancer Cachexia - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more